Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382057625> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4382057625 endingPage "74" @default.
- W4382057625 startingPage "74" @default.
- W4382057625 abstract "Introduction: Tricohepatoenteric syndrome (THES) is a complex condition that confers a poor life prognosis. We describe a conventional multivisceral transplant (MVT) in a patient with THES type II (THES II), who developed multiple infectious complications and graft versus host disease (GVHD). Methods: Clinical, therapeutic and outcome of a MVT in a patient with THES II are analyzed. Results: A 7-year-old male patient who received a first conventional MVT due to the development of intestinal failure associated liver disease related to THES II is described. He had also severe colitis treated with tocilizumab and a humoral immunodeficiency with several studies of cellular immunity without alterations, so it was decided not to perform a hematopoietic stem cell transplant (HSCT) prior to the MVT. Transplant was performed with a non-depleting immunosuppression protocol with basiliximab, tacrolimus, and corticosteroid, with excellent immediate evolution, so he was discharged 46 days after MVT. Three months after MVT, he developed CMV and adenovirus infections, which required 3 admissions and multiple treatments, and the immunosuppression was changed to sirolimus at 5 months post-transplant. At 10 months post-transplant, being autonomous from the digestive point of view, he was admitted for chronic severe GVHD with ocular, cutaneous-mucous, and respiratory involvement. Intravenous corticotherapy at 2 mg/kg/day was iniciated without improvement, so ruxolitinib (2.5 mg/12h orally) was added, with clinical normalization and a decrease in the graft chimerism in peripheral blood from a maximum of 60% to 30%. During the admission, the patient presented a CMV reactivation in the blood which required treatment with foscarnet, and a dysfunction of the intestinal graft secondary to a norovirus infection, with a transient worsening of the GVHD clinical manifestations, probably due to malabsorption of ruxolitinib.13 months post-transplant, he showed a decrease in the three blood cell series, with bone marrow aplasia in a bone marrow biopsy. Ruxolitinib was discontinued because a potential bone marrow toxicity, with a reappearance of the GVHD without improvement of hematological manifestations. The patient died from P. Aeruginosa multiresistant sepsis at 15 months post-transplant. Conclusions: THES is a challenging condition. Normal cellular immunity studies may not rule out immunological abnormalities. Our patient developed complications suggesting of the existence of an underlying cellular immunodeficiency, due to the appearance of multiple infectious complications and a chronic severe GVHD. In tricohepatoenteric syndrome, regardless of the results of the immunological studies, it is necessary to carefully evaluate the possibility of performing an HSCT prior to the MVT." @default.
- W4382057625 created "2023-06-27" @default.
- W4382057625 creator A5031189796 @default.
- W4382057625 creator A5037742880 @default.
- W4382057625 creator A5043521713 @default.
- W4382057625 creator A5045011247 @default.
- W4382057625 creator A5048300065 @default.
- W4382057625 creator A5048723768 @default.
- W4382057625 creator A5050859453 @default.
- W4382057625 creator A5075255128 @default.
- W4382057625 creator A5083751130 @default.
- W4382057625 creator A5090636814 @default.
- W4382057625 creator A5092267310 @default.
- W4382057625 date "2023-06-27" @default.
- W4382057625 modified "2023-10-04" @default.
- W4382057625 title "127: CHRONIC GRAFT-VERSUS-HOST DISEASE AS THE MAIN COMPLICATION OF MULTIVISCERAL TRANSPLANT IN A PATIENT WITH TRICOHEPATOENTERIC SYNDROME TYPE II" @default.
- W4382057625 doi "https://doi.org/10.1097/01.tp.0000945964.66329.67" @default.
- W4382057625 hasPublicationYear "2023" @default.
- W4382057625 type Work @default.
- W4382057625 citedByCount "1" @default.
- W4382057625 crossrefType "journal-article" @default.
- W4382057625 hasAuthorship W4382057625A5031189796 @default.
- W4382057625 hasAuthorship W4382057625A5037742880 @default.
- W4382057625 hasAuthorship W4382057625A5043521713 @default.
- W4382057625 hasAuthorship W4382057625A5045011247 @default.
- W4382057625 hasAuthorship W4382057625A5048300065 @default.
- W4382057625 hasAuthorship W4382057625A5048723768 @default.
- W4382057625 hasAuthorship W4382057625A5050859453 @default.
- W4382057625 hasAuthorship W4382057625A5075255128 @default.
- W4382057625 hasAuthorship W4382057625A5083751130 @default.
- W4382057625 hasAuthorship W4382057625A5090636814 @default.
- W4382057625 hasAuthorship W4382057625A5092267310 @default.
- W4382057625 hasBestOaLocation W43820576251 @default.
- W4382057625 hasConcept C126322002 @default.
- W4382057625 hasConcept C141071460 @default.
- W4382057625 hasConcept C2777408962 @default.
- W4382057625 hasConcept C2779972918 @default.
- W4382057625 hasConcept C2780252810 @default.
- W4382057625 hasConcept C2780372218 @default.
- W4382057625 hasConcept C2781307858 @default.
- W4382057625 hasConcept C2909675724 @default.
- W4382057625 hasConcept C2911091166 @default.
- W4382057625 hasConcept C71924100 @default.
- W4382057625 hasConcept C81182388 @default.
- W4382057625 hasConcept C90924648 @default.
- W4382057625 hasConceptScore W4382057625C126322002 @default.
- W4382057625 hasConceptScore W4382057625C141071460 @default.
- W4382057625 hasConceptScore W4382057625C2777408962 @default.
- W4382057625 hasConceptScore W4382057625C2779972918 @default.
- W4382057625 hasConceptScore W4382057625C2780252810 @default.
- W4382057625 hasConceptScore W4382057625C2780372218 @default.
- W4382057625 hasConceptScore W4382057625C2781307858 @default.
- W4382057625 hasConceptScore W4382057625C2909675724 @default.
- W4382057625 hasConceptScore W4382057625C2911091166 @default.
- W4382057625 hasConceptScore W4382057625C71924100 @default.
- W4382057625 hasConceptScore W4382057625C81182388 @default.
- W4382057625 hasConceptScore W4382057625C90924648 @default.
- W4382057625 hasIssue "7S" @default.
- W4382057625 hasLocation W43820576251 @default.
- W4382057625 hasLocation W43820576252 @default.
- W4382057625 hasOpenAccess W4382057625 @default.
- W4382057625 hasPrimaryLocation W43820576251 @default.
- W4382057625 hasRelatedWork W1996102154 @default.
- W4382057625 hasRelatedWork W2003051278 @default.
- W4382057625 hasRelatedWork W2036845344 @default.
- W4382057625 hasRelatedWork W2040393718 @default.
- W4382057625 hasRelatedWork W2068303865 @default.
- W4382057625 hasRelatedWork W2132053129 @default.
- W4382057625 hasRelatedWork W2884628875 @default.
- W4382057625 hasRelatedWork W3002064010 @default.
- W4382057625 hasRelatedWork W3166469754 @default.
- W4382057625 hasRelatedWork W4254351441 @default.
- W4382057625 hasVolume "107" @default.
- W4382057625 isParatext "false" @default.
- W4382057625 isRetracted "false" @default.
- W4382057625 workType "article" @default.